Cancer Research AACR Conference on Molecular Diagnostics - 2008  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 931-939, February 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forrester, H. B.
Right arrow Articles by Dewey, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forrester, H. B.
Right arrow Articles by Dewey, W. C.
[Cancer Research 59, 931-939, February 15, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

Using Computerized Video Time Lapse for Quantifying Cell Death of X-irradiated Rat Embryo Cells Transfected with c-myc or c-Ha-ras1

Helen B. Forrester, Charles A. Vidair, Norman Albright, Clif C. Ling and William C. Dewey2

Radiation Oncology Research Laboratory, University of California San Francisco, San Francisco, California 94103-0806 [H. B. F., C. A. V., N. A., W. C. D.]; and Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [C. C. L.]

Rat embryo fibroblasts that had been transfected with the c-myc or c-Ha-ras oncogene were X-irradiated, after which individual cells and their progeny were followed in multiple fields for 5–6 days by computerized video time lapse microscopy to quantify the lethal events that resulted in loss of clonogenic survival. The loss of clonogenic survival of X-irradiated (9.5 or 2.5 Gy) REC:myc cells was attributed almost entirely to the cells dying by apoptosis, with almost all of the apoptosis occurring after the progeny had divided from one to four times. In contrast, the loss of clonogenic survival of X-irradiated REC:ras cells was attributed to two processes. After 9.5 Gy, ~60% of the nonclonogenic cells died by apoptosis (with a very small amount of necrosis), and the other 40% underwent a senescent-type process in which some of the cells and their progeny stopped dividing but remained as viable cells throughout 140 h of observation. Both processes usually occurred after the cells had divided and continued to occur in the cells’ progeny for up to five divisions after irradiation. Furthermore, the duration of the apoptotic process was shorter for REC:myc cells (0.5–1 h) than for REC:ras cells (4–5 h).

By using computerized video time lapse to follow individual cells, we were able to determine the mode of cell death. This cannot be determined by conventional clonogenic survival experiments. Also, only by following the individual cells and their progeny can the true amount of apoptosis be determined. The cumulative percentage of apoptosis scored in whole populations, without distinguishing between the progeny of individually irradiated cells, does not reflect the true amount of apoptosis that occurs in cells that undergo postmitotic apoptosis after irradiation. Scoring cell death in whole populations of cells gives erroneous results because both clonogenic and nonclonogenic cells are dividing as nonclonogenic cells are apoptosing or senescing over a period of many days. For example, after 9.5 Gy, which causes reproductive cell death in 99% of both types of cells, the cumulative percentage of the cells scored as dead in the whole population at 60- 80 h after irradiation, when the maximum amount of cumulative apoptosis occurred, was ~60% for REC:myc cells, compared with only ~40% for REC:ras cells.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Huang, L. Fletcher, N. Beeharry, R. Daniel, G. Kao, T. J. Yen, and R. J. Muschel
Abnormal Cytokinesis after X-Irradiation in Tumor Cells that Override the G2 DNA Damage Checkpoint
Cancer Res., May 15, 2008; 68(10): 3724 - 3732.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. R. Sekhar, V. N. Sonar, V. Muthusamy, S. Sasi, A. Laszlo, J. Sawani, N. Horikoshi, R. Higashikubo, R. G. Bristow, M. J. Borrelli, et al.
Novel Chemical Enhancers of Heat Shock Increase Thermal Radiosensitization through a Mitotic Catastrophe Pathway
Cancer Res., January 15, 2007; 67(2): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Abulaiti, A. J. Fikaris, O. M. Tsygankova, and J. L. Meinkoth
Ras Induces Chromosome Instability and Abrogation of the DNA Damage Response
Cancer Res., November 1, 2006; 66(21): 10505 - 10512.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. G. Syljuasen, C. S. Sorensen, J. Nylandsted, C. Lukas, J. Lukas, and J. Bartek
Inhibition of Chk1 by CEP-3891 Accelerates Mitotic Nuclear Fragmentation in Response to Ionizing Radiation
Cancer Res., December 15, 2004; 64(24): 9035 - 9040.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. Pajonk, K. Pajonk, and W. H. McBride
Inhibition of NF-{kappa}B, Clonogenicity, and Radiosensitivity of Human Cancer Cells
J Natl Cancer Inst, November 17, 1999; 91(22): 1956 - 1960.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.